T1	Participants 103 122	suppressed patients
T2	Participants 320 399	virologically suppressed patients (HIV-1 RNA <400 copies/mL for > or =3 months)
T3	Participants 400 439	on stable (> or =6 months) therapy with
T4	Participants 520 602	Eighty-nine suppressed patients > or =18 years old with CD4 counts >50 cells/mm(3)
T5	Participants 753 772	Eighty-one patients
